The overall aim of the current investigation is to conduct a systematic assessment of the relationship among m6A-related lncRNAs and CRC patient prognosis, the composition of tumor immune microenvironment (TIME), and expression of programmed death ligand 1 (PD-L1). Here, CD274 is linked to neoplasm.